Centrus Energy (LEU) launches $1B at-the-market equity program after Q3 results; stock slides on Nov. 6, 2025

Centrus Energy (LEU) launches $1B at-the-market equity program after Q3 results; stock slides on Nov. 6, 2025

  • $1 billion ATM equity program announced. Centrus Energy Corp. (NYSE American: LEU) filed an automatically effective shelf registration and a new at‑the‑market (“ATM”) program authorizing up to $1.0 billion in Class A common stock sales through a syndicate led by Barclays, Citigroup, UBS and Evercore ISI, among others. The prospectus supplement indicates agents earn a 1.5% commission on sales, and the prior 2024 ATM was terminated upon entry into the new Sales Agreement. Proceeds are for general corporate purposes, including technology investment, debt repayment, capex and potential acquisitions. [1]
  • Q3 2025 results mixed. For the quarter ended Sept. 30, 2025, Centrus reported revenue of $74.9M (+30% YoY) and net income of $3.9M (diluted EPS $0.19). Segment results: LEU revenue $44.8M and Technical Solutions $30.1M; the company posted a $4.3M gross loss as lower average prices for SWU offset uranium sales growth. [2]
  • Shares fall on the news. As of publication, LEU traded around $271.78, down ~16% intraday.

Centrus unveils $1B equity program to fund growth

Before the U.S. market open on Thursday, Centrus launched a $1 billion ATM equity program, enabling it to sell shares “from time to time” at prevailing market prices. According to the SEC‑filed prospectus supplement, the agent group includes Barclays, Citi, UBS, Evercore ISI, B. Riley, Guggenheim, MUFG, William Blair, Lake Street Capital Markets, and Northland; agent compensation is 1.5% of gross sales. The filing also notes Centrus terminated its prior 2024 ATM upon signing the new Sales Agreement. [3]

In its press release, the company said net proceeds may fund technology investment, debt repayment, capital expenditures, acquisitions, and other general corporate purposes—giving Centrus flexibility as it scales enrichment capacity and its HALEU program. The shares will be issued under an automatic shelf (Form S‑3ASR, File No. 333‑291305) that became effective today under Rule 462(e). [4]

An accompanying Form 8‑K filed today details the Sales Agreement parties and confirms that Centrus has no obligation to sell any specific amount under the ATM, with the program expiring once the full amount is sold or earlier termination by the company/agents. [5]


Third‑quarter 2025: revenue up, margins pressured

Centrus reported Q3 2025 revenue of $74.9 million (vs. $57.7 million a year ago) and net income of $3.9 million (diluted EPS $0.19), reflecting a stronger top line but a quarter of gross loss ($4.3M) due largely to lower average SWU pricing and product mix in the LEU segment. Segment detail from the company’s 10‑Q shows:

  • LEU revenue $44.8M; cost of sales $52.6M; gross loss $7.8M.
  • Technical Solutions revenue $30.1M; cost of sales $26.6M; gross profit $3.5M.
    Management attributed the Technical Solutions revenue growth primarily to increased activity under the DOE HALEU Operation Contract; DOE also extended Phase 2 through Oct. 31, 2025 as negotiations continued to definitize portions of that work. [6]

The company’s press release likewise highlighted the +31% Technical Solutions revenue increase and the quarter’s gross loss tied to LEU/SWU dynamics, aligning with details in the SEC filing. [7]


Market reaction: LEU stock falls double‑digits

Centrus shares dropped sharply in Thursday trading following the ATM announcement and the mixed margin picture, recently changing hands near $271.78, down ~16% intraday. (Price updates in the live chart below.)


Why the raise now? HALEU, capacity and policy tailwinds

Centrus remains one of the few U.S. players positioned to supply high‑assay low‑enriched uranium (HALEU)—fuel enriched between 5% and 20%—needed for many advanced reactors. U.S. policy has been moving to onshore HALEU supply and reduce reliance on Russia; in Oct. 2024, the DOE awarded initial HALEU production contracts to multiple firms (including Centrus’s American Centrifuge Operating unit), a program that could reach $2.7 billion depending on appropriations. [8]

On the operations front, Centrus has said it is planning a multi‑billion‑dollar expansion at its Piketon, Ohio facility, targeting at least 300 new operations jobs (hiring underway) and 1,000 construction jobs—contingent on federal funding decisions for LEU and HALEU. The company pitched the expansion alongside state and regional partners in late September. [9]


Call notes & backlog (what we’re watching)

On this morning’s call, management discussed the quarterly results and order pipeline; third‑party call summaries indicate total company backlog around $3.9 billion spanning deliveries into 2040—a figure investors will watch as Centrus times potential ATM share sales against contract wins and funding milestones. [10]


What today’s news means for investors

  • Balance‑sheet flexibility: The ATM bolsters liquidity without forcing a single large, discounted deal. But it also introduces near‑term dilution risk if shares are sold while volatility is elevated. [11]
  • Execution on HALEU/LEU: Margin volatility—especially in SWU pricing—was on display this quarter. Securing and delivering higher‑margin HALEU volumes and advancing the Piketon expansion could help mix and scale effects over time. [12]
  • Policy catalyst path: DOE contracting and any Congressional appropriations tied to domestic HALEU build‑out remain key external drivers. [13]

The bottom line

On Nov. 6, 2025, Centrus Energy (LEU) paired a $1B ATM launch with Q3 results that showed solid top‑line growth but pressured margins, sending the stock lower intraday. The raise gives Centrus optionality to fund HALEU and enrichment capacity at a moment when U.S. policy is pushing for domestic supply. Investors will be watching the pace of any ATM sales, DOE funding decisions, and signs that higher‑value HALEU output and long‑dated contracts can stabilize profitability. [14]

Disclosure: This article is for informational purposes only and does not constitute investment advice.

Centrus Energy CEO talks about its role as nuclear energy grows as a key climate solution

References

1. www.sec.gov, 2. www.prnewswire.com, 3. www.sec.gov, 4. www.prnewswire.com, 5. www.sec.gov, 6. www.sec.gov, 7. www.prnewswire.com, 8. www.reuters.com, 9. www.centrusenergy.com, 10. www.investing.com, 11. www.sec.gov, 12. www.sec.gov, 13. www.reuters.com, 14. www.sec.gov

Stock Market Today

  • Exxon Mobil (XOM) Tops 13F Watchlist: 16 Funds Hold XOM in 06/30/2025 Filings
    November 6, 2025, 1:20 PM EST. At Holdings Channel, the latest batch of 13F filings for the 06/30/2025 period shows Exxon Mobil Corp (Symbol: XOM) being held by 16 of the funds reviewed. The data highlight that 9 funds increased their XOM positions since 03/31/2025, while 7 trimmed theirs. Across all 134 filers, aggregate XOM shares rose by 247,700 to 4,646,049-a roughly 5.63% gain. As always with 13F data, beware that long positions are disclosed but short bets aren't, so the picture can be only partially revealing. Still, the move suggests continued institutional interest in XOM and provides a starting point for further research on the hedge fund landscape.
  • VNQ Held by 15 Hedge Funds in Latest 06/30/2024 13F Filings
    November 6, 2025, 1:18 PM EST. In the latest batch of 13F filings for the 06/30/2024 period, VNQ was held by 15 funds. Note that 13F filings reflect only long positions and omit short bets, so the full risk picture isn't shown. Among the group, 4 funds increased their VNQ positions since 03/31/2024, 6 trimmed, and 1 opened a new stake. Global Assets Advisory LLC exited VNQ as of 06/30/2024. Across the 2,247 filers reviewed, aggregate VNQ shares declined about 2.30%, from 47,325,921 to 46,239,409. The analysis shows how aggregating filings can reveal sentiment shifts, even when single filings can be misleading in isolation.
  • TT Draws Attention: 15 Funds Hold Trane Technologies in Latest 13F Batch (03/31/2025)
    November 6, 2025, 1:17 PM EST. At Holdings Channel, the latest batch of 13F filings for 03/31/2025 shows Trane Technologies (TT) is held by 15 funds. Note that 13F filings disclose only long positions; shorts aren't required to be reported, so the picture can be partial. Among the batch, 7 funds raised TT shares since 12/31/2024 and 8 trimmed positions. Across all funds that reported TT on 03/31/2025, aggregate TT shares rose by 521,712 to 51,865,359 - about a 1.02% increase from 51,343,647 at 12/31/2024. The piece points to the top holders and promises continuing coverage of how TT positions evolve across groups of filers.
  • Lam Research (LRCX) Among 7 Funds in Latest 13F Filings (03/31/2025)
    November 6, 2025, 1:14 PM EST. New review of the 13F filings for 03/31/2025 shows Lam Research Corp (LRCX) is held by 7 of the 26 funds in the latest batch. The piece cautions that 13F filings disclose long positions only and may miss shorts, so the picture can be incomplete. Across the batch, aggregate LRCX shares rose about 2.55%, from 506,794,121 to 519,697,853 shares between 12/31/2024 and 03/31/2025. Within this batch, 1 fund increased, 4 decreased, and 2 opened new positions; Ethos Financial Group LLC exited LRCX. The article notes that comparing groups of funds can reveal themes and stock ideas worth further research, including Lam Research Corp (LRCX).
  • Stock futures flat as AI-led pullback cools November start: Live market updates
    November 6, 2025, 1:11 PM EST. Stock futures were little changed after an AI-driven stretch, but the session saw major indices retreat as Palantir and other AI names led losses. The S&P 500 fell about 1.2%, the Nasdaq dropped ~2.0%, and the Dow slid ~0.5%. Palantir tumbled ~8% despite beating estimates and guiding higher, highlighting lofty valuations after a year of AI-driven gains. The forward P/E for the S&P 500 rose above 23, near the highest since 2000, as investors weigh whether profits will justify capex. Analysts like Anthony Saglimbene warned the rally could be stretched, while comments from Goldman Sachs and Morgan Stanley executives pointed to potential drawdowns in the next 12-24 months. A period of consolidation may be in store even with robust fundamentals.
Brad Heppner Indictment: Beneficient Founder and Ex‑GWG Chair Arrested—What We Know Today (Nov. 6, 2025)
Previous Story

Brad Heppner Indictment: Beneficient Founder and Ex‑GWG Chair Arrested—What We Know Today (Nov. 6, 2025)

Stocks Slip as Tech Wobble Returns; Layoffs Spike and Tariff Showdown Clouds Outlook — Stock Market Today (Nov. 6, 2025)
Next Story

Stocks Slip as Tech Wobble Returns; Layoffs Spike and Tariff Showdown Clouds Outlook — Stock Market Today (Nov. 6, 2025)

Go toTop